About Penta
Who we are
Diversity and Inclusion
Our Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
COVID and HIV: Psychological impact and awareness of COVID-19 in young people with HIV
PAIRED PANDEMICS: Ensuring HIV Care Continuity and Market Stability During COVID-19
Launch of Global Accelerator for Paediatric Formulations (GAP-f) by WHO
c4c publishes first peer reviewed publication
European research networks to facilitate drug research in children
Penta Projects in Schools: What do young people know about HIV?
How European Paediatric emergency departments responded to the first wave of SARS-CoV-2 Pandemic
Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets
World Patient Safety Day | 2020
World Sepsis Day
Delegates – Zanzibar training (2018)
Actual problems of HIV Infection: Mother and Child
The effect of pregnancy on the pharmacokinetics of total and unbound Dolutegravir and its main metabolite in women living with Human Immunodeficiency Virus
Clinically significant lower elvitegravir exposure during third trimester of pregnant patients living with HIV: data from the PANNA study
NeoVanc trial in the final stretch towards completion!
WSC Spotlight: Sepsis, Pandemics, and Antimicrobial Resistance – Global Health Threats of the 21st Century
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
A reason to SMILE – we reached Last Patient Last Visit